Literature DB >> 29296385

Stereotactic radiosurgery for high-grade metastatic epidural cord compression.

Ian Lee1, Melvin Omodon1, Jack Rock1, Lonni Shultz1,2, Samuel Ryu1,3.   

Abstract

PURPOSE: The standard of care of patients with high-grademetastatic epidural compression is open decompression with or without stabilization. However, many patients are unwilling or unable to undergo open surgical decompression. This study investigated the outcomes of treating patients with high-grade (Ryu/Rock radiographic grade IV and V, Spine Oncology Study Group Grade II and III) metastatic epidural spinal cord compression with spinal radiosurgery as first-line therapy in lieu of surgical decompression.
METHODS: Utilizing the Henry Ford Spinal Tumor Database, patients with metastatic lesions causing advanced radiographical grade (IV or V) epidural spinal cord compression who received stereotactic radiosurgery (SRS)with adequate clinical and radiological follow-up were identified from 2007-2011. These patients were retrospectively reviewed for clinical and radiological response to radiosurgery.
RESULTS: 33 patients with 35 metastatic lesions causing Ryu/Rock radiographical grade IV or V compression were identified with a median follow-up of 435 days. Of the 34 lesions in 32 patients who were ambulatory pre-SRS, 23 (67%) were ambulatory at last follow-up. 6/33 progressed early (less than 2 months) neurologically and an additional 5 patients developed late progressive neurologic deficit. The one patient who was initially non-ambulatory was able to regain ambulatory status. Radiologically, there was a significant epidural tumor response rate of 74%. Ultimately, 9 patients (27%) eventually required surgery for neurologic compromise or mechanical instability. There was one patient who received EBRT previously who experienced radiation myelopathy as a complication of SRS.
CONCLUSION: Radiosurgery as an initial therapy for high-grade metastatic epidural compression appears to be a viable treatment paradigm for selected patients with close clinical and radiological follow-up. However, a significant minority will progress necessitating the need for rigorous monitoring. Further study is needed prospectively analyze the effectiveness of SRS with or without open surgical decompression.

Entities:  

Keywords:  Metastatic Epidural Compression; Radiosurgery; Spinal metastasis; Stereotactic Radiosurgical decompression; Stereotactic radiation therapy; Tumor

Year:  2014        PMID: 29296385      PMCID: PMC5725330     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  23 in total

1.  Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Authors:  Samuel Ryu; Fang Fang Yin; Jack Rock; Jingeng Zhu; Archie Chu; Eduard Kagan; Lisa Rogers; Munther Ajlouni; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

2.  Dosimetric characteristics of Novalis shaped beam surgery unit.

Authors:  Fang-Fang Yin; Jingeng Zhu; Hui Yan; Haiqun Gaun; Rabih Hammoud; Samuel Ryu; Jae H Kim
Journal:  Med Phys       Date:  2002-08       Impact factor: 4.071

3.  Radiosurgical decompression of metastatic epidural compression.

Authors:  Samuel Ryu; Jack Rock; Rajan Jain; Mei Lu; Joseph Anderson; Jian-Yue Jin; Mark Rosenblum; Benjamin Movsas; Jae Ho Kim
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

4.  Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients.

Authors:  S Helweg-Larsen
Journal:  Acta Neurol Scand       Date:  1996-10       Impact factor: 3.209

5.  Spinal metastases from solid tumors. Analysis of factors affecting survival.

Authors:  P J Sioutos; E Arbit; C F Meshulam; J H Galicich
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

6.  Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression.

Authors:  F Bach; B H Larsen; K Rohde; S E Børgesen; F Gjerris; T Bøge-Rasmussen; N Agerlin; B Rasmusson; P Stjernholm; P S Sørensen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Authors:  Dirk Rades; Lukas J A Stalpers; Theo Veninga; Rainer Schulte; Peter J Hoskin; Nermina Obralic; Amira Bajrovic; Volker Rudat; Rudolf Schwarz; Maarten C Hulshof; Philip Poortmans; Steven E Schild
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

8.  Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery.

Authors:  Samuel Ryu; Jian-Yue Jin; Ryan Jin; Jack Rock; Munther Ajlouni; Benjamin Movsas; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

9.  Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.

Authors:  R W Gilbert; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

10.  Use of magnetic resonance imaging in the evaluation of metastatic spinal disease.

Authors:  J C Godersky; W R Smoker; R Knutzon
Journal:  Neurosurgery       Date:  1987-11       Impact factor: 4.654

View more
  3 in total

1.  Will immunotherapy change the role of spine radiosurgery in high-grade epidural disease? A case report and a call for an update of current treatment algorithms.

Authors:  Christina Kehl Cramer; James D Ververs; Frederick Scott Jones; Wesley Hsu; Michael David Chan; Stacey Quintero Wolfe
Journal:  J Radiosurg SBRT       Date:  2019

Review 2.  Evaluating ambulatory function as an outcome following treatment for spinal metastases: a systematic review.

Authors:  Lananh Nguyen; Nicole Agaronnik; Marco L Ferrone; Jeffrey N Katz; Andrew J Schoenfeld
Journal:  Spine J       Date:  2021-05-13       Impact factor: 4.297

3.  Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.

Authors:  Pierre G Thirion; Mary T Dunne; Paul J Kelly; Aileen Flavin; Joe M O'Sullivan; Dayle Hacking; Wojciech Sasiadek; Cormac Small; Maeve M Pomeroy; Joseph Martin; Orla McArdle; Imelda Parker; Lydia S O'Sullivan; Aoife M Shannon; Angela Clayton-Lea; Conor D Collins; Michael R Stevenson; Alberto Alvarez-Iglesias; John G Armstrong; Michael Moriarty
Journal:  Br J Cancer       Date:  2020-03-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.